Lite Strategy, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $0.00 per share for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2020-11-10
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2019-09-30 was $6.89, a 7.27% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2019-03-31 was $7.43.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2018-09-30 was $7.43, a 146.84% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2020 was $6.89, a 16.99% decline from fiscal 2019.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2019 was $8.30, a 22.78% increase from fiscal 2018.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2018 was $6.76, a 25.96% decline from fiscal 2017.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2017 was $9.13, a 37.29% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | $6.89 10-K · filed 2020-09-09 | |||
| 2020-03-31 | $6.89 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $6.89 10-Q · filed 2020-02-06 | |||
| 2019-09-30 | $6.89 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | $8.30 10-K · filed 2019-08-28 | |||
| 2019-03-31 | $7.43 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $7.43 10-Q · filed 2019-02-07 | |||
| 2018-09-30 | $7.43 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $6.76 10-K · filed 2018-08-30 | |||
| 2018-03-31 | $6.74 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | $5.26 10-Q · filed 2018-02-08 | |||
| 2017-09-30 | $3.01 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | $9.13 10-K · filed 2017-09-05 | |||
| 2017-03-31 | $9.15 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | $9.98 10-Q · filed 2017-02-08 | |||
| 2016-09-30 | $11.38 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $6.65 10-K · filed 2016-09-06 | |||
| 2016-03-31 | $5.53 10-Q · filed 2016-05-05 | |||
| 2015-12-31 | $5.23 10-Q · filed 2016-02-05 | |||
| 2015-09-30 | $4.62 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $17.83 10-K · filed 2015-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |